Basil A. Horst

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Linking Transcriptomic and Imaging Data Defines Features of a Favorable Tumor Immune Microenvironment and Identifies a Combination Biomarker for Primary Melanoma”.

Linking Transcriptomic and Imaging Data Defines Features of a Favorable Tumor Immune Microenvironment and Identifies a Combination Biomarker for Primary Melanoma

Cancer Research(2020)10.1158/0008-5472.can-19-2039

N/A

0DataRank · unranked

31 citations

Andrew Chen, Emanuelle M. Rizk, Douglas K. Marks, Margaret H. Bogardus, Thomas D. Hart +12 more

Effect of automated TIL quantification in early-stage melanoma on accuracy of standard T staging using AJCC guidelines.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10076

N/A

0DataRank · unranked

2 citations

Isabel D. Friesner, Emanuelle M. Rizk, Megan H. Trager, Jülide Tok Çelebi, Jeani Rich +15 more

Automated digital TIL analysis (ADTA) adds prognostic value to standard assessment of depth and ulceration in primary melanoma

Scientific Reports(2021)10.1038/s41598-021-82305-1

N/A

0DataRank · unranked

26 citations

Isabel D. Friesner, Emanuelle M. Rizk, Benjamin T. Fullerton, Manas Mondal, Megan H. Trager +24 more

Combination immunotherapy including OncoVEXmGMCSF creates a favorable tumor immune micro-environment in transgenic BRAF murine melanoma

Cancer Immunology Immunotherapy(2022)10.1007/s00262-021-03088-y

N/A

0DataRank · unranked

5 citations

Zoë Blake, Emanuelle M. Rizk, Rolando Pérez‐Lorenzo, Stuart P. Weisberg, Inês Simões +14 more

B7‐H3 drives immunosuppression and Co‐targeting with CD47 is a new therapeutic strategy in β‐catenin activated melanomas

Pigment Cell & Melanoma Research(2023)10.1111/pcmr.13091

N/A

0DataRank · unranked

6 citations

Tiphaine Martin, Nikki S. Vyas, Garrett Desman, Karen Mendelson, Basil A. Horst +3 more

Data from Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II–III Melanoma

(2023)10.1158/1078-0432.c.6528354

N/A

0DataRank · unranked

0 citations

Douglas K. Marks, Emanuelle M. Rizk, Margaret H. Bogardus, Camille L. Gérard, Luke W. Barker +15 more

Pathomic immune biomarkers define recurrence risk in early-stage melanoma

The Oncologist(2025)10.1093/oncolo/oyaf327

N/A

0DataRank · unranked

2 citations

Ajay Singh, Gerardo Espinoza, Chenxin Zhang, Tianyun Jiang, Divya Kenchappa +19 more